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The number of participants was so large that the organizers were forced to stop admitting participants when the total reached 15,105 because of the limit on resources. The initial contact at the workplace, followed by the extended battery of examinations, was very well received.
After ten years, the main players in this project, i.e. the ELSA-Brasil subjects, were still all actively participating through responding to telephone contacts year after year. A second wave of visits was organized in 2012-14 and a third wave of visits in 2017-18. So far, more than 200 original articles using data from ELSA-Brasil have been published; 100 theses and dissertations have been defended; more than 1,000 master's and doctoral students and clinical research fellows have been trained and then incorporated into the labor market; and Brazilian epidemiology has been integrated with the main scientific centers worldwide.
The impact of ELSA-Brasil cannot be measured solely in terms of its publications. Brazilian studies have begun to adopt the research methods of this study and the cryobiology model.
Clinical laboratories have adopted standards that were obtained through ELSA-Brasil, rather than using those coming from foreign populations. However, the most important outcome has been the production of guidelines for application in the Brazilian National Health System relating to diet, hypertension, diabetes, renal disorders, mental disorders, cognitive dysfunction, headache and thyroid diseases. It completes a virtuous cycle: funding from the Ministry of Health for science has produced returns that benefit all citizens through a new approach towards non-communicable diseases.
The trajectory of ELSA-Brasil shows that it is possible for Brazilian scientists to work together with common goals over the long term, while revealing the high proportion of selfless people who are willing to volunteer with actions that will benefit everyone for a long time.
Going back to what happened at the summit meeting of world epidemiology in the United States in March 2018: Brazil does not have a nuclear arsenal, but it is armed with science to improve the living conditions of humanity, thereby contributing towards understanding the relationship between health and disease.
References: Access to the complete collection of ELSA-Brasil papers can be requested from palotufo@usp.br
